Related Experiment Video
Updated: Jun 4, 2026

A Novel Procedure for Evaluating the Reinforcing Properties of Tastants in Laboratory Rats: Operant Intraoral Self-administration
Published on: February 6, 2014
[Drug control of appetite]
1Service d'enseignement thérapeutique pour maladies chroniques, Centre collaborateur de l'OMS, Département de médecine communautaire, de premier recours et des urgences, HUG, 1211 Genève 14. vincent.makoundou@hcuge.ch
Abstract:
The control of the appetite by drugs (sensation of hunger, satiation and satiety) is crucial in the management of obesity. Numerous drugs in this domain were forbidden these last years because of serious side effects. New researches allow the development of new substances presenting fewer side effects either by better specificity on receptors (locarserin), or by new mechanism of action (GLP-1, leptin, anti Ghrelin). The appetite is settled by a complex neurohormonal mechanism. To act on some systems at the same time, the development of products "polypill" combining naltroxone-bupropion, phentermine-topiramate or amylin-leptine give encouraging results. However the dominant mechanism of the appetite dysregulation needs to be better understood.
Related Concept Videos
Regulation of Food Intake
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Dependence
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

